Home
About
FAQ
History (3)
Eliminating the improbable: Sherlock Holmes and standards of evidence in the genomic age.
Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis.
Leprosy, Paucibacillary
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Eliminating the improbable: Sherlock Holmes and standards of evidence in the genomic age.
Herrington D. Eliminating the improbable: Sherlock Holmes and standards of evidence in the genomic age. Circulation. 2005 Oct 04; 112(14):2081-4.
View in:
PubMed
subject areas
Genetic Diseases, Inborn
Genome, Human
Humans
Reproducibility of Results
authors with profiles
David M. Herrington MD, MHS